Skip to main content
CVE-2026-112351VulnerabilityPublished

Sunhillo SureLine before 9.1.5 contains an OS command injection vulnerability in the networkDiag.cgi endpoint that

Source GCVE Database

0

Mentioned vulnerabilities

Authoritative record:CVE-2026-112351· High 8.7

Not known to be exploited · CVSS 8.7 High : upgrade to 9.1.5 soon.

Data as of 27 Oct 2026, 22:13 UTC

CVSS 4.0 base score
8.7High
How severe the flaw is on the 0–10 CVSS scale.
Patch
Available – fixed in 9.1.5
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 27 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade SureLine to 9.1.5.

Affected software

ProductAffectedFixed in
Sunhillo CorporationSureLineAffected
  • >=8.6.0 <9.1.5
Fixed in
  • 9.1.5

AI-suggested

If you cannot patch yet, restrict access to the networkDiag.cgi endpoint to trusted users only and monitor for suspicious activity involving this endpoint.

Description

Sunhillo SureLine versions before 9.1.5 have an OS command injection vulnerability in the networkDiag.cgi endpoint. Authenticated remote attackers with any web account can exploit this flaw by injecting shell metacharacters into the ipAddr or dnsAddr parameters. The vulnerability allows bypassing a prior fix's incomplete character denylist using URL-encoded newline or ampersand sequences, enabling execution of arbitrary commands as root. This leads to full system compromise.

References

Community reviews

Loading reviews…